ProQR Therapeutics NV (PRQR) stock has gained 11.63% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With PRQR Stock Today?
ProQR Therapeutics NV (PRQR) stock is trading at $4.32 as of 1:18 PM on Monday, Nov 23, an increase of $0.12, or 2.74% from the previous closing price of $4.20. The stock has traded between $4.23 and $4.55 so far today. Volume today is 306,921 compared to average volume of 332,789.
To screen for more stocks like ProQR Therapeutics NV click here.
More About ProQR Therapeutics NV
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
Click Here to get the full Stock Score Report on ProQR Therapeutics NV (PRQR) Stock.
